ATE286912T1 - Schlangenproteine mit antithrombotischer wirkung - Google Patents

Schlangenproteine mit antithrombotischer wirkung

Info

Publication number
ATE286912T1
ATE286912T1 AT01123277T AT01123277T ATE286912T1 AT E286912 T1 ATE286912 T1 AT E286912T1 AT 01123277 T AT01123277 T AT 01123277T AT 01123277 T AT01123277 T AT 01123277T AT E286912 T1 ATE286912 T1 AT E286912T1
Authority
AT
Austria
Prior art keywords
beta
alpha
amino acid
strand
protein
Prior art date
Application number
AT01123277T
Other languages
English (en)
Inventor
Naoyuki Fukuchi
Morikazu Kito
Takashi Kayahara
Fumie Futaki
Kohki Ishikawa
Eiichiro Suzuki
Keiko Gondoh
Nobuhisa Shimba
Naoyuki Yamada
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE286912T1 publication Critical patent/ATE286912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01123277T 2000-10-04 2001-10-04 Schlangenproteine mit antithrombotischer wirkung ATE286912T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000305279A JP2002112782A (ja) 2000-10-04 2000-10-04 抗血栓活性を有する蛋白質及びその製造法

Publications (1)

Publication Number Publication Date
ATE286912T1 true ATE286912T1 (de) 2005-01-15

Family

ID=18786175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01123277T ATE286912T1 (de) 2000-10-04 2001-10-04 Schlangenproteine mit antithrombotischer wirkung

Country Status (5)

Country Link
US (2) US6710031B2 (de)
EP (1) EP1195384B1 (de)
JP (1) JP2002112782A (de)
AT (1) ATE286912T1 (de)
DE (1) DE60108326T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101100059B1 (ko) * 2004-06-30 2011-12-29 넥타르 테라퓨틱스 중합체­인자 ｉｘ 부분의 접합체
ES2352204T3 (es) 2004-10-19 2011-02-16 Lonza Ag Método de síntesis peptídica en fase sólida.
US8907053B2 (en) * 2010-06-25 2014-12-09 Aurigene Discovery Technologies Limited Immunosuppression modulating compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
FI904330A7 (fi) * 1988-09-29 1990-09-03 Biogen Inc Hirudiinipeptidejä
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
WO1995008573A1 (en) * 1993-09-22 1995-03-30 Ajinomoto Co., Inc. Peptide having antithrombotic activity and process for producing the same
JPH0937785A (ja) 1995-05-25 1997-02-10 Ajinomoto Co Inc ヌクレオシド−５’−燐酸エステルの製造法
JP4304727B2 (ja) 1996-11-21 2009-07-29 味の素株式会社 ヌクレオシド−５’−燐酸エステルの製造法

Also Published As

Publication number Publication date
DE60108326T2 (de) 2005-12-22
US7084113B2 (en) 2006-08-01
US20020198363A1 (en) 2002-12-26
DE60108326D1 (de) 2005-02-17
EP1195384B1 (de) 2005-01-12
JP2002112782A (ja) 2002-04-16
EP1195384A1 (de) 2002-04-10
US6710031B2 (en) 2004-03-23
US20040161822A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
MX9705727A (es) Variantes de amilasa.
DE69130506D1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
CA2352537A1 (en) Tgf.beta.1-inhibitor peptides
PT96208A (pt) Processo de obtencao de uma sequencia de adn codificando um derivado recombinante do factor viii humano, de um vector e de celula recombinante e de preparacao do referido derivado.
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
CY1112833T1 (el) Καινοφανης προσδετης της κυτοκινης ζcυτοr17
RU2002123286A (ru) Слитый белок с увеличенной эритропоэтиновой активностью, нуклеиновая кислота, кодирующая слитый белок, и способ получения слитого белка
ATE441666T1 (de) Antikírper gegen den fibroblastenwachstumsfaktor 23
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
DE60335726D1 (de) Chromoprotein und fluoroproteine
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
ATE286912T1 (de) Schlangenproteine mit antithrombotischer wirkung
EP0933427A3 (de) Beta-Carotinhydroxylase Gen
BG101226A (bg) Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
SG109959A1 (en) 5-substituted hydantoin recemase, dna coding for the same, recombinant dna, transformed cells, and process for producing optically active amino acids
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
DE69518764D1 (de) Peptide mit entzündungshemmende aktivität
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE251640T1 (de) Neues chondrozytprotein
KR930701600A (ko) 안정적이고 생물활성적인 변형된 소마토트로핀
EA200100440A1 (ru) Ген prv-1 и его применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties